Cipla Ltd has informed to the exchanges regarding termination of Stock Purchase and Merger Agreement (“the SPMA”) with Avenue Therapeutics Inc.
The Company notified that the SPMA entered between InvaGen Pharmaceuticals Inc. (“InvaGen”), USA, wholly owned step down subsidiary of the Company, and Avenue Therapeutics Inc (“Avenue”) has been terminated with effect from November 01, 2021.
However, the ‘Stockholders Agreement’ dated November 12, 2018 between InvaGen, Avenue and other stockholders remains in force; and InvaGen will continue to hold shares in Avenue, said Cipla in a regulatory filing on Wednesday.
At around 12:12 PM, Cipla was trading at Rs923.70 per piece up by Rs16.85 or 1.86% on Sensex.
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
